EUVIMEDEUVIMED entdecken
Crossref

Insulin-Induced NF-κB Activation May Contribute to Doxorubicin Resistance in Luminal A T-47D Breast Cancer Cells

Wibisono Hasanul Muhtaram, Novrita Padauleng, Rizka Vidya Lestari

Lombok Medical Journal · 31.07.2026 · 5 (3) · 114-121

DOI: 10.29303/jzdrrk18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lombok Medical Journal, online erschienen am 31.07.2026. Verfasst von Wibisono Hasanul Muhtaram und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is an effective chemotherapy agent for breast cancer; however, its efficacy is often limited by cellular resistance. Insulin is hypothesized to enhance anti-apoptotic activity through activation of Nuclear Factor Kappa-Beta (NF-κB), although its mechanism in the Luminal A subtype T-47D cell line has not been extensively studied. This analytical experimental study with a post-test only paired design used T-47D cells divided into insulin-treated and non-insulin groups. Both groups were exposed to various concentrations of doxorubicin, namely 0 (control), 3.125, 6.25, 12.5, 25, 50, and 100 µg/mL. NF-κB activation was measured as pNF-κB concentration using the ELISA method. Data were analyzed using the Shapiro–Wilk test for normality followed by a paired t-test. The insulin-treated group showed higher mean pNF-κB concentrations compared to the non-insulin group across all doxorubicin doses. Significant differences were observed at 0 µg/mL (p = 0.008), 3.125 µg/mL (p = 0.009), and 100 µg/mL (p = 0.045), whereas no significant differences were found at concentrations between 6.25 and 50 µg/mL (p > 0.05). Overall, increasing doxorubicin concentrations reduced pNF-κB levels; however, insulin treatment maintained higher pNF-κB levels compared to the non-insulin group. These findings indicate that insulin increases NF-κB activation in doxorubicin-treated T-47D breast cancer cells and may sustain NF-κB activity against the cytotoxic effects of doxorubicin.

Zitieren

APA

Muhtaram, W. H., Padauleng, N., & Lestari, R. V. (2026). Insulin-Induced NF-κB Activation May Contribute to Doxorubicin Resistance in Luminal A T-47D Breast Cancer Cells. Lombok Medical Journal, 5(3), 114-121. https://doi.org/10.29303/jzdrrk18

Vancouver

Muhtaram WH, Padauleng N, Lestari RV. Insulin-Induced NF-κB Activation May Contribute to Doxorubicin Resistance in Luminal A T-47D Breast Cancer Cells. Lombok Medical Journal. 2026;5(3):114-121. doi:10.29303/jzdrrk18

BibTeX
@article{Muhtaram2026,
  author = {Muhtaram, Wibisono Hasanul and Padauleng, Novrita and Lestari, Rizka Vidya},
  title = {Insulin-Induced NF-κB Activation May Contribute to Doxorubicin Resistance in Luminal A T-47D Breast Cancer Cells},
  journal = {Lombok Medical Journal},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {114--121},
  doi = {10.29303/jzdrrk18}
}
Kostenlos starten →